LACTOVIVE- lactobacillus acidophilus, bifidobacterium animalis lactis capsule 
Lifsa Drugs LLC

----------

LactoVive

72336-172-30

PROBIOTIC SUPPORT

DIETARY SUPPLEMENT

DISPENSED BY PRESCRIPTION

DESCRIPTION

LactoVive is an orally administered prescription probiotic dietary supplement.

Supplement Facts
Serving size 1 Capsule
Amount per Serving:% Daily Value
*
Daily value not established
Lactobacillus Acidophilus16 Billion*
Bifidobacterium Animalis Lactis15 Billion*

Inactive Ingredients:

Vegetable Capsules

Hydroxypropyl Methylcellulose, Silicon Dioxide, Magnesium Stearate.

Preservative Free and Gluten Free

INDICATIONS

LactoVive is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed. LactoVive should be administered under the supervision of a licensed medical practitioner.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

LactoVive should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.

ADVERSE REACTIONS

You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact Lifsa Drugs, LLC at 1-800-FDA-1088

DOSAGE AND ADMINISTRATION

Usual adult dose is 1 capsule once or twice daily or as prescribed by a licensed medical practitioner.

HOW SUPPLIED

Bottle of 30 capsules (72336-172-30)

STORAGE AND HANDLING

Store 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Avoid excessive heat, light, moisture and exceeding 85% humidity. Keep in a cool, dry place.

TAMPER EVIDENT: Do not use if seal is broken or missing.

31 Billion CFU's verified at the time of production.

Manufactured For:

Lifsa Drugs, LLC

New Brunswick NJ 08901

MADE IN USA

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

PRINCIPAL DISPLAY PANEL - 30 Capsule Bottle Label

72336-172-30

Lactobacillus Acidophilus
Bifidobacterium Animalis Lactis
31 Billion CFU's
30 CAPSULES

LactoVive-3

LACTOVIVE 
lactobacillus acidophilus, bifidobacterium animalis lactis capsule
Product Information
Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:72336-172
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LACTOBACILLUS ACIDOPHILUS (UNII: 1PRR1V42V5) (LACTOBACILLUS ACIDOPHILUS - UNII:1PRR1V42V5) LACTOBACILLUS ACIDOPHILUS16000000000 [CFU]
BIFIDOBACTERIUM ANIMALIS LACTIS (UNII: 5307V7XW8I) (BIFIDOBACTERIUM ANIMALIS LACTIS - UNII:5307V7XW8I) BIFIDOBACTERIUM ANIMALIS LACTIS15000000000 [CFU]
Inactive Ingredients
Ingredient NameStrength
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:72336-172-3030 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Dietary Supplement02/25/2025
Supplement Facts
Serving Size : Serving per Container :
Amount Per Serving% Daily Value
color
scoring1
shape
size (solid drugs)23 mm
Labeler - Lifsa Drugs LLC (081205160)

Revised: 3/2025
Document Id: df0be4d1-f2c7-4d96-9014-7dbc6b1cfaec
Set id: ee98f4b2-1fd0-463a-a31b-32f3b7fd83d1
Version: 1
Effective Time: 20250318
 
Lifsa Drugs LLC